Ibsa Pharma Limited
Registered name: IBSA PHARMA LIMITED
Ibsa Pharma Limited made £22.5m revenue and £412k profit in the year to 31 Dec 2025.
Ibsa Pharma Limited’s revenue grew 10% to £22.5m in the year to 31 Dec 2025, with £412k profit and 49 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Watford; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Watford, East of England
- Age
- 26 yrs · since 2000
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “IBSA Institut Biochimique SA”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £11.5m | £17.7m | £20.5m | £22.5m |
| Cost of sales | £5.5m | £12.4m | £13.8m | £14.1m |
| Gross profit | £6m | £5.3m | £6.6m | £8.4m |
| Operating profit | £4m | £633k | £785k | £467k |
| Profit before tax | £4m | £742k | £908k | £555k |
| Profit after tax | £3.3m | £568k | £673k | £412k |
| Profit (best available) | £3.3m | £568k | £673k | £412k |
| Staff costs | £1.6m | £2.4m | £2.8m | £3.8m |
| Employees (average) | 29 | 40 | 40 | 49 |
| Ratios | ||||
| Profit margin | 28.7% | 3.2% | 3.3% | 1.8% |
| Gross margin | 52% | 29.9% | 32.4% | 37.2% |
| Revenue per employee | £398k | £441k | £511k | £460k |
| Profit per employee | £114k | £14.2k | £16.8k | £8.4k |
| Cash conversion | −20.3% | −348.4% | 326.8% | −176.1% |
| Growth (year on year) | ||||
| Revenue growth | — | — | ▲15.8% | ▲10.1% |
| Profit growth | — | — | ▲18.6% | ▼38.8% |
| Headcount growth | — | — | 0% | ▲22.5% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £10.7m | £6.9m | £4.3m | £3.4m |
| Net assets | £12.7m | £7.2m | £7.9m | £8.3m |
| Fixed assets | £136k | £124k | £586k | £642k |
| Current assets | £15.8m | £11.8m | £12.4m | £11.5m |
| Debtors | £1.4m | £1.4m | £1.5m | £1.5m |
| Deferred income | £461k | £562k | £636k | — |
| Cash from operations | −£818k | −£2.2m | £2.6m | −£823k |
| Source | FullAccounts · bulk data Apr 2024 | FullAccounts · bulk data Apr 2024 | FullAccounts · bulk data Feb 2025 | FullAccounts · bulk data Feb 2026 |
How the business works
- Profit margin
- 1.8%
- Profit ÷ revenue.
- Gross margin
- 37.2%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £460k
- Revenue ÷ average employees.
- Profit per employee
- £8.4k
- Profit ÷ average employees.
- Cash conversion
- −176.1%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 2.9%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 6.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲5%
- Now £8.3m
- Cash at bank
- ▼20%
- Now £3.4m
- Headcount
- ▲23%
- Now 49
- Deferred income
- —
- Now —
- Fixed assets
- ▲10%
- Now £642k
Similar profitable businesses
- Agrihealth (N.i.) LimitedLurgan · Wholesale of pharmaceutical goods
- Revenue
- £22.7m
- Profit
- £1.1m
- Staff
- 60
- Mylife Diabetes Care LtdEscrick · Wholesale of pharmaceutical goods
- Revenue
- £23.5m
- Profit
- £537k
- Staff
- 39
- GN Hearing UK LtdBicester · Wholesale of pharmaceutical goods
- Revenue
- £23.6m
- Profit
- £858k
- Staff
- 49
- Paul Hartmann LimitedPilsworth Road · Wholesale of pharmaceutical goods
- Revenue
- £21.4m
- Profit
- £277k
- Staff
- 81
- Medi UK LtdWholesale of pharmaceutical goods
- Revenue
- £23.9m
- Profit
- £1.8m
- Staff
- 42
- Crest Medical LimitedWarrington · Wholesale of pharmaceutical goods
- Revenue
- £24.3m
- Profit
- £829
- Staff
- 82
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £412k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.